Anna Sebestyén

2.9k total citations · 1 hit paper
103 papers, 1.9k citations indexed

About

Anna Sebestyén is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Anna Sebestyén has authored 103 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 32 papers in Cancer Research and 24 papers in Oncology. Recurrent topics in Anna Sebestyén's work include PI3K/AKT/mTOR signaling in cancer (19 papers), Cancer, Hypoxia, and Metabolism (19 papers) and Glycosylation and Glycoproteins Research (7 papers). Anna Sebestyén is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (19 papers), Cancer, Hypoxia, and Metabolism (19 papers) and Glycosylation and Glycoproteins Research (7 papers). Anna Sebestyén collaborates with scholars based in Hungary, United States and South Korea. Anna Sebestyén's co-authors include László Kopper, Titanilla Dankó, Ildikó Krencz, Gábor Petővári, Melinda Hajdu, József Tı́már, Gyula Végső, Gábor Barna, Rudolf Mihalik and Ilona Kovalszky and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Anna Sebestyén

99 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Formation of a protein corona on the surface of extracellular vesicles in blood plasma

2021 289 citations Lilla Turiák, Tamás Visnovitz et al. Journal of Extracellular Vesicles profile →

Peers

Countries citing papers authored by Anna Sebestyén

Since Specialization

Citations

This map shows the geographic impact of Anna Sebestyén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Sebestyén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Sebestyén more than expected).

Fields of papers citing papers by Anna Sebestyén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Sebestyén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Sebestyén. The network helps show where Anna Sebestyén may publish in the future.

Co-authorship network of co-authors of Anna Sebestyén

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Sebestyén. A scholar is included among the top collaborators of Anna Sebestyén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Sebestyén. Anna Sebestyén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Defactinib in Combination with Mitotane Can Be an Effective Treatment in Human Adrenocortical Carcinoma 2025 ·International Journal of Molecular Sciences ·Henriett Butz, Lőrinc Sándor Pongor, (unknown), (unknown), Katalin Dezső, Titanilla Dankó, Anna Sebestyén, (unknown), József Tóvári, (unknown), István Likó, Katalin Mészáros, Andrea Deák, (unknown), (unknown), (unknown), Erika Tóth, Péter Igaz, Attila Patócs	0
2	Fluid Dynamics Optimization of Microfluidic Diffusion Systems for Assessment of Transdermal Drug Delivery: An Experimental and Simulation Study 2024 ·Scientia Pharmaceutica ·(unknown), S. Dhinakaran, (unknown), András József Laki, (unknown), (unknown), Miléna Lengyel, (unknown), (unknown), Anna Sebestyén, (unknown), István Antal, Franciska Erdő	1
3	Cyclodextrin encapsulation enabling the anticancer repositioning of disulfiram: Preparation, analytical and in vitro biological characterization of the inclusion complexes 2024 ·International Journal of Pharmaceutics ·(unknown), Gergő Tóth, (unknown), (unknown), Edina Szabó, Zoltán‐István Szabó, Márta Kraszni, Lajos Szente, Béla Fiser, Anna Sebestyén, Romána Zelkó, István Sebe	8
4	Tumorigenic role of tacrolimus through mTORC1/C2 activation in post-transplant renal cell carcinomas 2024 ·British Journal of Cancer ·(unknown), (unknown), Titanilla Dankó, (unknown), Gábor Petővári, (unknown), (unknown), Gyula Végső, László Piros, Ádám Hosszú, Judit Pápay, Ildikó Krencz, Anna Sebestyén	1
5	Antimicrobial Peptides (AMP) in the Cell-Free Culture Media of Xenorhabdus budapestensis and X. szentirmaii Exert Anti-Protist Activity against Eukaryotic Vertebrate Pathogens including Histomonas meleagridis and Leishmania donovani Species 2023 ·Antibiotics ·András Fodor, Claudia Hess, Petra Ganas, (unknown), János Kiss, László Makrai, Károly Dublecz, László Pál, László Fodor, Anna Sebestyén, Michael G. Klein, Eustachio Tarasco, Manjusha Kulkarni, Bradford S. McGwire, Tibor Vellai, Michael Heß	2
6	Clinical, pharmacological, and formulation evaluation of disulfiram in the treatment of glioblastoma - a systematic literature review 2023 ·Expert Opinion on Drug Delivery ·(unknown), Dimitrios A. Lamprou, Anna Sebestyén, Romána Zelkó, István Sebe	5
7	Extracellular Vesicle-Mediated Metastasis Suppressors NME1 and NME2 Modify Lipid Metabolism in Fibroblasts 2022 ·Cancers ·(unknown), Gábor Petővári, Titanilla Dankó, Henriett Butz, István Likó, Péter Lőw, Isabelle Petit, Randa Bittar, Dominique Bonnefont‐Rousselot, Zsolt Farkas, Tamás Szeniczey, Kinga Molnár, Krisztina Pálóczi, Edit I. Buzás, Mathieu Boissan, Anna Sebestyén, Krisztina Takács‐Vellai	8
8	Folic Acid Treatment Directly Influences the Genetic and Epigenetic Regulation along with the Associated Cellular Maintenance Processes of HT-29 and SW480 Colorectal Cancer Cell Lines 2022 ·Cancers ·(unknown), Alexandra Kalmár, Barbara Kinga Barták, Zsófia Brigitta Nagy, (unknown), Gábor Valcz, (unknown), Titanilla Dankó, Anna Sebestyén, Gábor Barna, Orsolya Pipek, István Csabai, Zsolt Tulassay, Péter Igaz, István Takács, Béla Molnár	7
9	Survival of HT29 Cancer Cells Is Affected by IGF1R Inhibition via Modulation of Self-DNA-Triggered TLR9 Signaling and the Autophagy Response 2022 ·Pathology & Oncology Research ·Ferenc Sípos, (unknown), (unknown), (unknown), Titanilla Dankó, (unknown), Gábor Petővári, (unknown), Barnabás Wichmann, Anna Sebestyén, Györgyi Műzes	7
10	Survival of HT29 cancer cells is influenced by hepatocyte growth factor receptor inhibition through modulation of self-DNA-triggered TLR9-dependent autophagy response 2022 ·PLoS ONE ·(unknown), (unknown), (unknown), Titanilla Dankó, (unknown), Gábor Petővári, (unknown), Anna Sebestyén, Ferenc Sípos, Györgyi Műzes	5
11	In Situ Analysis of mTORC1/C2 and Metabolism-Related Proteins in Pediatric Osteosarcoma 2022 ·Pathology & Oncology Research ·(unknown), Ildikó Krencz, (unknown), (unknown), (unknown), (unknown), (unknown), Anna Sebestyén, Monika Csóka	4
12	Formation of a protein corona on the surface of extracellular vesicles in blood plasma breakdown → 2021 ·Journal of Extracellular Vesicles ·(unknown), Lilla Turiák, Tamás Visnovitz, Csaba Cserép, Anett Mázló, Barbara W. Sódar, András Försönits, Gábor Petővári, Anna Sebestyén, Zsolt István Komlósi, László Drahos, Ágnes Kittel, György Nagy, Attila Bácsi, Ádám Dénes, Yong Song Gho, Katalin Szabó-Taylor, Edit I. Buzás	289
13	Rapamycin Plus Doxycycline Combination Affects Growth Arrest and Selective Autophagy-Dependent Cell Death in Breast Cancer Cells 2021 ·International Journal of Molecular Sciences ·Titanilla Dankó, Gábor Petővári, (unknown), (unknown), (unknown), Péter Lőrincz, Tamás Visnovitz, (unknown), Gábor Barna, (unknown), Ildikó Krencz, Anna Sebestyén	21
14	Promoter Hypomethylation and Increased Expression of the Long Non-coding RNA LINC00152 Support Colorectal Carcinogenesis 2020 ·Pathology & Oncology Research ·Orsolya Galamb, Alexandra Kalmár, Anna Sebestyén, Titanilla Dankó, (unknown), István Fűri, Péter Hollósi, István Csabai, Barnabás Wichmann, Tibor Krenács, Barbara Kinga Barták, Zsófia Brigitta Nagy, (unknown), (unknown), Zsolt Tulassay, Péter Igaz, Béla Molnár	14
15	S-Adenosylmethionine Treatment of Colorectal Cancer Cell Lines Alters DNA Methylation, DNA Repair and Tumor Progression-Related Gene Expression 2020 ·Cells ·(unknown), Alexandra Kalmár, Zsófia Brigitta Nagy, Barbara Kinga Barták, Gábor Valcz, (unknown), Orsolya Galamb, Titanilla Dankó, Anna Sebestyén, Gábor Barna, (unknown), Orsolya Pipek, (unknown), István Csabai, Zsolt Tulassay, Péter Igaz, István Takács, Béla Molnár	18
16	Extracellular Vesicle-Based Communication May Contribute to the Co-Evolution of Cancer Stem Cells and Cancer-Associated Fibroblasts in Anti-Cancer Therapy 2020 ·Cancers ·Gábor Valcz, Edit I. Buzás, Anna Sebestyén, Tibor Krenács, Zoltán Szállási, Péter Igaz, Béla Molnár	11
17	Characterization of mTOR Activity and Metabolic Profile in Pediatric Rhabdomyosarcoma 2020 ·Cancers ·(unknown), Ildikó Krencz, (unknown), Noémi Nagy, Gábor Petővári, Titanilla Dankó, Tamás Micsík, András Khoór, Tamás Tornóczky, Zoltàn Sápi, Anna Sebestyén, Monika Csóka	8
18	Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas 2020 ·Cancers ·Balázs Sarkadi, Katalin Mészáros, Ildikó Krencz, Letizia Canu, (unknown), (unknown), (unknown), Anna Sebestyén, Judit Pápay, (unknown), Henriett Butz, (unknown), Péter Igaz, Judit Dóczi, Michaela Luconi, Christos Chinopoulos, Attila Patócs	20
19	Ex vivo organotypic culture system of precision-cut slices of human pancreatic ductal adenocarcinoma 2019 ·Scientific Reports ·Sougat Misra, Carlos Fernández Moro, Marco Del Chiaro, (unknown), Anna Sebestyén, Matthias Löhr, Mikael Björnstedt, Caroline S. Verbeke	75
20	mTOR activity and its prognostic significance in human colorectal carcinoma depending on C1 and C2 complex-related protein expression 2016 ·Journal of Clinical Pathology ·(unknown), (unknown), (unknown), (unknown), Noémi Nagy, Gyula Végső, Tamás Micsík, László Kopper, Anna Sebestyén	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact